A note on disease burden and pharmaceutical R&D
Year of publication: |
2023
|
---|---|
Authors: | Mohan, Vijay ; Nabin, Munirul |
Published in: |
Australian economic papers. - Oxford [u.a.] : Wiley-Blackwell, ISSN 1467-8454, ZDB-ID 2006503-6. - Vol. 62.2023, 4, p. 633-649
|
Subject: | disease burden | intellectual property rights | pharmaceutical R&D | Immaterialgüterrechte | Intellectual property rights | Arzneimittel | Pharmaceuticals | Pharmaindustrie | Pharmaceutical industry | Krankheit | Disease | Arzneimittelmarkt | Pharmaceutical market | Gesundheitskosten | Health care costs |
-
Pharmaceutical innovation and parallel trade
Bennato, Anna Rita, (2014)
-
Product patents and access to innovative medicines in a post-trips-era
Watal, Jayashree, (2019)
-
Optimal patent policy for pharmaceutical industry
Izhak, Olena, (2020)
- More ...
-
Mass Reproducibility and Replicability: A New Hope
Brodeur, Abel, (2024)
-
Licensing under vertical product differentiation : price vs. quantity competition
Nguyễn-Thanh-Xuân, (2014)
-
On the relationship between technology transfer and economic growth in Asian economies
Nabin, Munirul, (2013)
- More ...